$ARRY, Array BioPharma reports 3Q loss Assoc
Post# of 22756
Array BioPharma reports 3Q loss
[Associated Press]
Associated PressMay 10, 2017
BOULDER, Colo. (AP) _ Array BioPharma Inc. (ARRY) on Wednesday reported a loss of $35.3 million in its fiscal third quarter.
The Boulder, Colorado-based company said it had a loss of 21 cents per share.
The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 16 cents per share.
The drug developer posted revenue of $33.3 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $47 million.
Array BioPharma shares have decreased 20 percent since the beginning of the year. The stock has more than doubled in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARRY at https://www.zacks.com/ap/ARRY
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'